Omega Healthcare Investors, Inc. — Q3 2014 Form 10-Q Summary
Business context and reporting period
Omega is a healthcare real estate investment trust focused primarily on skilled nursing facilities. Its portfolio consists principally of triple-net leases, fixed-rate mortgage loans, and direct financing leases. The filing covers the three and nine months ended September 30, 2014, compared with the corresponding 2013 periods. The portfolio included 564 healthcare facilities in 38 states, operated by 50 third-party operators, with approximately 99% of real estate investments related to long-term care facilities.
Financial performance and key metrics
| Metric | Q3 2014 | Q3 2013 | 9M 2014 | 9M 2013 |
|---|---|---|---|---|
| Operating revenues | $130.7 million | $103.3 million | $373.5 million | $307.6 million |
| Net income available to common stockholders | $61.7 million | $38.1 million | $164.4 million | $125.3 million |
| Diluted EPS | $0.48 | $0.32 | $1.30 | $1.08 |
| FFO available to common stockholders | $93.9 million | $70.3 million | $258.0 million | $222.9 million |
| Dividends per share | $0.51 | $0.47 | $1.50 | $1.38 |
- Q3 operating revenues increased 26.5%; nine-month revenue increased 21.4%.
- Q3 net income increased 61.8%; nine-month net income increased 31.2%.
- Approximate operating margin was 70.6% in Q3 and 68.3% for the nine-month period, based on income before other income and expense divided by operating revenue. Net margin was approximately 47.2% and 44.0%, respectively.
- Operating cash flow was $259.6 million for the nine months, compared with $200.1 million in 2013.
- Investing cash flow was an outflow of $461.0 million, primarily reflecting $406.1 million of net mortgage investments and $47.5 million of property acquisitions.
- Financing cash flow was an inflow of $199.2 million. Cash and cash equivalents ended at $0.5 million, compared with $2.6 million at December 31, 2013; restricted cash was $31.8 million.
- Total assets were $3.86 billion and stockholders’ equity was $1.41 billion at September 30, 2014.
- Debt was approximately $2.30 billion, or 62.1% of total capitalization. Unsecured borrowings increased to $1.84 billion from $1.20 billion at December 31, 2013, while the revolving credit balance declined to $3.0 million from $326.0 million.
Material changes versus the prior comparable period
- Revenue growth was driven by $14.2 million of Q3 direct financing lease income and $42.4 million for the nine-month period from the New Ark transaction completed in November 2013, as well as higher mortgage interest income from new mortgage investments.
- Mortgage interest income increased to $16.9 million in Q3 from $7.3 million and to $36.1 million for nine months from $22.1 million.
- Operating expenses declined in Q3 by approximately $1.5 million but increased for nine months by approximately $3.4 million. Nine-month increases included $3.7 million of real estate impairments and $2.6 million of higher general and administrative expense, partly offset by lower depreciation.
- Interest expense increased by $6.4 million in Q3 and $12.3 million for nine months due to higher borrowings. Nine-month results also included refinancing-related charges, including deferred financing cost write-offs and debt prepayment costs.
- FFO increased 33.5% in Q3 and 15.8% for the nine-month period.
- Shares outstanding increased, with 127.4 million shares outstanding at September 30, 2014 versus 123.5 million at December 31, 2013, reflecting equity shelf issuances and the dividend reinvestment plan.
Outlook, commentary, risks, contingencies and unusual items
- Management stated that liquidity, operating cash flow, available capacity under the 2014 credit facilities, and expected mortgage payoffs were adequate to fund operations, debt service, dividends, and investments for the next twelve months. No quantitative earnings or revenue guidance was provided.
- The company entered into a $1.2 billion unsecured credit facility, including a $1.0 billion revolving facility and a $200 million term loan, with an accordion feature allowing total commitments of up to $1.75 billion.
- Omega issued $250 million of 4.50% senior notes due 2025 and used the proceeds to repay revolving credit borrowings. It also issued $400 million of 4.95% senior notes due 2024 earlier in 2014.
- Q3 included a $2.1 million impairment charge on a closed Texas SNF and a $23 thousand impairment on a Vermont SNF classified as held for sale. One Indiana SNF was sold at a $20 thousand loss.
- Omega invested approximately $8.2 million in a Texas SNF during Q3 and completed additional 2014 property and mortgage investments, including a $415 million Michigan mortgage and a $112.5 million Pennsylvania/Ohio mortgage.
- On October 31, 2014, after quarter-end, Omega agreed to acquire Aviv REIT in a stock-based merger. Aviv holders were to receive 0.90 Omega share per Aviv share; completion was subject to stockholder, regulatory, financing and other conditions. Management identified integration, financing, dilution, transaction cost and execution risks.
- Key operating risks include tenant credit quality, operator bankruptcies, Medicare and Medicaid reimbursement changes, healthcare regulation, occupancy, interest rates, access to capital, concentration among operators and states, and maintaining REIT qualification.
- New Ark represented 13% of total investments and approximately 12% of Q3 and nine-month operating revenues. Genesis represented approximately 11% of operating revenues for both periods.
- Management stated that pending litigation was not expected to have a material adverse effect. Disclosure controls were assessed as effective as of September 30, 2014.
Important facts for investors to verify
- Confirm the completion terms, financing, dilution, final consideration and integration results of the proposed Aviv merger.
- Review tenant concentration and credit exposure, particularly New Ark, Genesis, Diversicare and operators dependent on Medicare and Medicaid reimbursement.
- Assess leverage, maturity schedules, variable-rate debt exposure and compliance with financial covenants.
- Reconcile FFO growth with GAAP earnings, impairments, refinancing costs and other non-recurring items.
- Monitor the collectability of straight-line rent and mortgage receivables, including the $0.8 million receivable provision and $2.0 million effective-yield receivable write-off recorded in 2014.
- Evaluate whether operating cash flow and credit capacity remain sufficient to fund dividends, debt service and planned acquisitions given the very low unrestricted cash balance.
- Verify the effect of reimbursement, regulatory, quality-of-care and licensing developments on operators’ ability to meet lease and mortgage obligations.